Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$4.06
0.184.64%
Last update: Dec 15, 3:03 PM
Comments
Loading...
Minerva Neurosciences (NERV) Stock Price, Quote, News & History
NERVNASDAQ
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Minerva Neurosciences (NERV) stock?
You can purchase shares of Minerva Neurosciences (NASDAQ:NERV) through any online brokerage.
Who are Minerva Neurosciences (NERV) competitors?
Other companies in Minerva Neurosciences’s space includes: Serina Therapeutics Inc (AMEX:SER), Intensity Therapeutics Inc (NASDAQ:INTS), Lunai Bioworks Inc (NASDAQ:LNAI), Nanoviricides Inc (AMEX:NNVC) and Barinthus Biotherapeutics PLC (NASDAQ:BRNS).
What is the forecast, or price target, for Minerva Neurosciences (NERV) stock?
Minerva Neurosciences has a consensus price target of $4.00.
What is the current price for Minerva Neurosciences (NERV)?
The stock price for Minerva Neurosciences (NASDAQ: NERV) is $4.06 last updated December 15, 2025 at 3:03 PM EST.
Does Minerva Neurosciences (NERV) pay a dividend?
There are no upcoming dividends for Minerva Neurosciences.
When is Minerva Neurosciences (NASDAQ:NERV) reporting earnings?
Minerva Neurosciences does not have any upcoming earnings scheduled.
Is Minerva Neurosciences (NERV) going to split?
There is no upcoming split for Minerva Neurosciences.
What sector and industry does Minerva Neurosciences (NERV) operate in?
Minerva Neurosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
